Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
NCT04398732
·
clinicaltrials.gov ↗
COMPLETED
Status
486
Enrollment
INDUSTRY
Sponsor class
Conditions
Plaque Psoriasis
Interventions
DRUG:
Enbrel
Sponsor
Pfizer